Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bosentan in Scleroderma Renal Crisis
NCT01241383Phase 2Completed
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Dec 2010
- Primary completion
- Oct 2015
- Modality
- Nucleic Acid-Directed Small Molecules, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of bosentan in scleroderma renal crisis (SRC), sponsored by Assistance publique - Hôpitaux de Paris. Started Dec 2010; status: completed.
02
Drugs
bosentan
03
Conditions
scleroderma renal crisis (SRC)
Beyond the preview
Go deeper on NCT01241383.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01241383.